Clínica Universitaria de Navarra -ko ikertzaileekin lankidetzan egindako argitalpenak (3)

2014

  1. Randomized placebo-controlled phase II trial of autologous mesenchymal stem cells in multiple sclerosis

    PLoS ONE, Vol. 9, Núm. 12

2008

  1. HLA-DR2 and white matter lesion distribution in MS

    Journal of Neuroimaging, Vol. 18, Núm. 3, pp. 328-331

  2. IL-10 suppressor activity and ex vivo Tr1 cell function are impaired in multiple sclerosis

    European Journal of Immunology, Vol. 38, Núm. 2, pp. 576-586